Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Vaccine. 2009 Sep 25;27(42):5830-6. doi: 10.1016/j.vaccine.2009.07.052. Epub 2009 Aug 4.

    Estradiol improves genital herpes vaccine efficacy in mice.

    Source

    Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.

    Abstract

    Herpes Simplex Virus type 2 causes genital herpes but is frequently transmitted asymptomatically; therefore, a prophylactic vaccine is desirable. A candidate vaccine in clinical trials has only shown efficacy in preventing disease in women. Using this subunit vaccine candidate, we were able to demonstrate infection prophylaxis, improved disease prevention and modulated antibody production by complimenting vaccination with estradiol in our murine model. Findings of estradiol-enhanced vaccine efficacy are the first of their kind using a vaccine of this type and have potential clinical relevance to the development of other vaccines and our understanding of gender differences in vaccine efficacy.

    PMID:
    19660586
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2749618
    Free PMC Article

    Images from this publication.See all images (2)Free text

    FIG. 1
    FIG. 2

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk